Hypertension, Vol 21, 491-497, Copyright © 1993 by American Heart Association
E Vicaut and X Hou
Intravital microscopy was used in a preparation of rat cremaster muscle
that was isolated from its normal blood supply and externally perfused with
a physiological solution, thus allowing exclusion of circulating converting
enzyme, renin, and angiotensinogen. The arterioles studied were classified
as second-, third-, and fourth-order arterioles with mean diameters of
60.5, 29.9, and 14.8 microns, respectively. Topical administration of 1
nmol/mL angiotensin I or 1 nmol/mL tetradecapeptide renin substrate induced
marked vasoconstrictions (i.e., 38.5%, 61.5%, and 90.1% and 25%, 34%, and
88% for second-, third-, and fourth-order arterioles with angiotensin I and
tetradecapeptide renin substrate, respectively). The angiotensin converting
enzyme inhibitor quinapril significantly inhibited the vasoconstrictions
caused by either angiotensin I or tetradecapeptide renin substrate. Almost
no vasoconstriction was found when angiotensinogen-rich renin-free plasma
containing either 2.45 nmol/mL of angiotensinogen or 1.2 micrograms/mL
renin was administered. Conversely, these two compounds induced significant
constrictions in cremaster muscle preparations in which normal blood
perfusion (and thus circulating renin and angiotensinogen) was left in
place. We concluded that, in skeletal muscle, 1) the microvascular network
is a very effective site of local angiotensin converting enzyme activity
and consequently an important target site of angiotensin converting enzyme
inhibitors; 2) the effects of tetradecapeptide renin substrate are very
different from those of angiotensinogen from plasma and suggest that a
large part of the effect of tetradecapeptide renin substrate was due to its
nonspecific hydrolysis; and 3) at the microvascular level, circulating
renin and angiotensinogen are more effective in inducing arteriolar
constriction, in the presence of their substrate or associated enzyme, than
local renin and angiotensinogen.
ARTICLES
Arteriolar constriction and local renin-angiotensin system in rat microcirculation
Laboratoire de Biophysique, Hopital F. Widal, Paris, France.
This article has been cited by other articles:
![]() |
G. J Dietze and E. J Henriksen Review: Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 75 - 88. [Abstract] [PDF] |
||||
![]() |
K. Tamura, S. Umemura, N. Nyui, T. Yamakawa, S. Yamaguchi, T. Ishigami, S.-i. Tanaka, K. Tanimoto, N. Takagi, H. Sekihara, et al. Tissue-Specific Regulation of Angiotensinogen Gene Expression in Spontaneously Hypertensive Rats Hypertension, June 1, 1996; 27(6): 1216 - 1223. [Abstract] [Full Text] |
||||
![]() |
D. N. Muller, K. F. Hilgers, J. Bohlender, A. Lippoldt, J. Wagner, W. Fischli, D. Ganten, J. F. E. Mann, and F. C. Luft Effects of Human Renin in the Vasculature of Rats Transgenic for Human Angiotensinogen Hypertension, August 1, 1995; 26(2): 272 - 278. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |